Lenvatinib + farletuzumab ecteribulin

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Lenvatinib + farletuzumab ecteribulin
Treatment and conditionWhere it standsTrials
Lenvatinib + farletuzumab ecteribulin for adenocarcinomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lenvatinib + farletuzumab ecteribulin for endometrial neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1